{"id": "article-142041_0", "title": "ABO Blood Group System -- Continuing Education Activity", "content": "In the early 1900s, the four different blood types within the ABO blood group system were identified. Knowledge of these blood types and the implications associated with ABO incompatibility has improved patient care and decreased associated morbidity. This activity reviews the ABO blood group system, highlights complications of ABO incompatibility, and emphasizes the appropriate selection of blood products by the interprofessional team-based on ABO blood typing.", "contents": "ABO Blood Group System -- Continuing Education Activity. In the early 1900s, the four different blood types within the ABO blood group system were identified. Knowledge of these blood types and the implications associated with ABO incompatibility has improved patient care and decreased associated morbidity. This activity reviews the ABO blood group system, highlights complications of ABO incompatibility, and emphasizes the appropriate selection of blood products by the interprofessional team-based on ABO blood typing."}
{"id": "article-142041_1", "title": "ABO Blood Group System -- Continuing Education Activity", "content": "Objectives: Describe the ABO blood group system antigens and antibodies. Review the blood typing methods and reasons why discrepancies in blood typing can occur. Summarize typical scenarios of hemolysis due to ABO incompatibility. Identify appropriate blood products that should be ordered for patients in the context of their ABO blood type. Access free multiple choice questions on this topic.", "contents": "ABO Blood Group System -- Continuing Education Activity. Objectives: Describe the ABO blood group system antigens and antibodies. Review the blood typing methods and reasons why discrepancies in blood typing can occur. Summarize typical scenarios of hemolysis due to ABO incompatibility. Identify appropriate blood products that should be ordered for patients in the context of their ABO blood type. Access free multiple choice questions on this topic."}
{"id": "article-142041_2", "title": "ABO Blood Group System -- Introduction", "content": "The ABO blood group system was first discovered in the early 1900s, and since that time, our understanding of the ABO blood group system has increased significantly.\u00a0 These discoveries have led to safer transfusion practices. [1] [2] The ABO blood group system spans beyond transfusion medicine and has been used in the study of populations by anthropologists, police in forensic science, and lawyers in paternity claims.", "contents": "ABO Blood Group System -- Introduction. The ABO blood group system was first discovered in the early 1900s, and since that time, our understanding of the ABO blood group system has increased significantly.\u00a0 These discoveries have led to safer transfusion practices. [1] [2] The ABO blood group system spans beyond transfusion medicine and has been used in the study of populations by anthropologists, police in forensic science, and lawyers in paternity claims."}
{"id": "article-142041_3", "title": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies", "content": "People can be divided into four main groups (A, B, O, and AB) based on the agglutination patterns of their red blood cells. The ABO blood group system consists of A and B antigens on red blood cells and their\u00a0corresponding\u00a0antibodies in the sera of people who do not express those antigens. [1] [2] ABO antigens exist on the surface of red blood cells as well as the surfaces of the other tissues and secretions. Anti-A and anti-B antibodies are naturally-occurring and are made by immunocompetent people starting at approximately six months of age. [3] [4]", "contents": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies. People can be divided into four main groups (A, B, O, and AB) based on the agglutination patterns of their red blood cells. The ABO blood group system consists of A and B antigens on red blood cells and their\u00a0corresponding\u00a0antibodies in the sera of people who do not express those antigens. [1] [2] ABO antigens exist on the surface of red blood cells as well as the surfaces of the other tissues and secretions. Anti-A and anti-B antibodies are naturally-occurring and are made by immunocompetent people starting at approximately six months of age. [3] [4]"}
{"id": "article-142041_4", "title": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies", "content": "The A and B blood group antigens are oligosaccharide antigens generated by reactions catalyzed by glycosyltransferases. The expression of these antigens determines the blood type of the patient.\u00a0The human ABO gene is found on chromosome 9; it spans over 18 kilobases and is made up of 7 coding exons.\u00a0 Functional A and B alleles encode the A and B glycosyltransferases, leading to the synthesis of A and B antigens. Due to nucleotide substitutions leading to amino acid substitutions, A and B genes encode the A and B transferases with different sugar specificities. The O genes are not active because they cannot produce functional enzymes.", "contents": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies. The A and B blood group antigens are oligosaccharide antigens generated by reactions catalyzed by glycosyltransferases. The expression of these antigens determines the blood type of the patient.\u00a0The human ABO gene is found on chromosome 9; it spans over 18 kilobases and is made up of 7 coding exons.\u00a0 Functional A and B alleles encode the A and B glycosyltransferases, leading to the synthesis of A and B antigens. Due to nucleotide substitutions leading to amino acid substitutions, A and B genes encode the A and B transferases with different sugar specificities. The O genes are not active because they cannot produce functional enzymes."}
{"id": "article-142041_5", "title": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies", "content": "Group O individuals have an H gene found on chromosome 19, forming the H-antigen. This antigen serves as a precursor oligosaccharide needed to form the A and B antigens. H antigens are abundantly noted in type O individuals. If the A and B genes are both present, then some of the H becomes A, and some become B, forming the AB group. If the H gene is defective or not present, then the H antigen cannot be formed, and therefore A or B cannot be formed. The consequence is a\u00a0rare\u00a0phenotype known as the Bombay phenotype. Patients with the Bombay phenotype have antibodies in the plasma similar to those present in the plasma of type O individuals, but they also have clinically significant anti-H antibodies. [3] [5] [4]", "contents": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies. Group O individuals have an H gene found on chromosome 19, forming the H-antigen. This antigen serves as a precursor oligosaccharide needed to form the A and B antigens. H antigens are abundantly noted in type O individuals. If the A and B genes are both present, then some of the H becomes A, and some become B, forming the AB group. If the H gene is defective or not present, then the H antigen cannot be formed, and therefore A or B cannot be formed. The consequence is a\u00a0rare\u00a0phenotype known as the Bombay phenotype. Patients with the Bombay phenotype have antibodies in the plasma similar to those present in the plasma of type O individuals, but they also have clinically significant anti-H antibodies. [3] [5] [4]"}
{"id": "article-142041_6", "title": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies", "content": "Based on the pattern and degree of agglutination using reference antibodies and red blood cells, subgroups of ABO have also been identified. Subgroups are distinguished by decreased amounts of A, B, or O (H) antigens on the red blood cells. Blood type A has the most variation with different subgroups; type A1 has the standard amount of antigen A, with decreasing amounts of this antigen noted in the subsequent subtypes. [5]", "contents": "ABO Blood Group System -- Function -- ABO Antigens and Antibodies. Based on the pattern and degree of agglutination using reference antibodies and red blood cells, subgroups of ABO have also been identified. Subgroups are distinguished by decreased amounts of A, B, or O (H) antigens on the red blood cells. Blood type A has the most variation with different subgroups; type A1 has the standard amount of antigen A, with decreasing amounts of this antigen noted in the subsequent subtypes. [5]"}
{"id": "article-142041_7", "title": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing", "content": "Before a transfusion, ABO typing is routinely performed to provide the safest transfusion possible. Forward typing (antigen typing for A and B on red cells) and reverse typing (testing for anti-A and anti-B in the patient\u2019s plasma) are performed. The forward and reverse typing are performed to confirm the blood type. However, discrepancies between forward and reverse typing may occur. The discordance can be due to a lack or excess of antigens or antibodies.\u00a0 If a discrepancy is found, the first step is to perform confirmatory assessments to evaluate for any errors in testing or technical problems.\u00a0 Various clinical scenarios can also explain these discrepancies.", "contents": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing. Before a transfusion, ABO typing is routinely performed to provide the safest transfusion possible. Forward typing (antigen typing for A and B on red cells) and reverse typing (testing for anti-A and anti-B in the patient\u2019s plasma) are performed. The forward and reverse typing are performed to confirm the blood type. However, discrepancies between forward and reverse typing may occur. The discordance can be due to a lack or excess of antigens or antibodies.\u00a0 If a discrepancy is found, the first step is to perform confirmatory assessments to evaluate for any errors in testing or technical problems.\u00a0 Various clinical scenarios can also explain these discrepancies."}
{"id": "article-142041_8", "title": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing", "content": "In forward typing, the patient\u2019s red blood cells are combined with commercial antisera.\u00a0 Weaker RBC agglutination than expected (weak or missing reactivity) can occur in cases of A or B subgroups.\u00a0 Additional RBC reactivity on forward typing can occur in cases of acquired B phenomenon.\u00a0The acquired B phenotype occurs in cases where bacterial enzymatic changes lead to the conversion of N-acetylgalactosamine (A antigen) into galactose (B antigen); this phenomenon has been documented in cases of bacterial infections and colorectal malignancy. [6] [7]", "contents": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing. In forward typing, the patient\u2019s red blood cells are combined with commercial antisera.\u00a0 Weaker RBC agglutination than expected (weak or missing reactivity) can occur in cases of A or B subgroups.\u00a0 Additional RBC reactivity on forward typing can occur in cases of acquired B phenomenon.\u00a0The acquired B phenotype occurs in cases where bacterial enzymatic changes lead to the conversion of N-acetylgalactosamine (A antigen) into galactose (B antigen); this phenomenon has been documented in cases of bacterial infections and colorectal malignancy. [6] [7]"}
{"id": "article-142041_9", "title": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing", "content": "Reverse ABO typing combines a patient\u2019s plasma with commercial red blood cells. Possible causes of weaker than expected plasma reactivity include immunosuppression, very young or old age, hypogammaglobulinemia, and prior treatment with rituximab.\u00a0 Unexpected or \u201cextra\u201d reactivity detected in reverse typing can be seen in patients who have received intravenous immune globulin (IVIG) or non-ABO-matched plasma products. [8]", "contents": "ABO Blood Group System -- Issues of Concern -- Discrepancies in Blood Typing. Reverse ABO typing combines a patient\u2019s plasma with commercial red blood cells. Possible causes of weaker than expected plasma reactivity include immunosuppression, very young or old age, hypogammaglobulinemia, and prior treatment with rituximab.\u00a0 Unexpected or \u201cextra\u201d reactivity detected in reverse typing can be seen in patients who have received intravenous immune globulin (IVIG) or non-ABO-matched plasma products. [8]"}
{"id": "article-142041_10", "title": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products", "content": "In the simplest terms, individuals with type O blood are considered \u201cuniversal donors\u201d for red blood cells, and type AB patients are \u201cuniversal recipients\u201d for red cells from patients with any ABO blood type. Type AB plasma is compatible with all other ABO blood types.\u00a0 There are, however, many caveats and clinical scenarios to consider when choosing the safest and most appropriate blood products for each patient.", "contents": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products. In the simplest terms, individuals with type O blood are considered \u201cuniversal donors\u201d for red blood cells, and type AB patients are \u201cuniversal recipients\u201d for red cells from patients with any ABO blood type. Type AB plasma is compatible with all other ABO blood types.\u00a0 There are, however, many caveats and clinical scenarios to consider when choosing the safest and most appropriate blood products for each patient."}
{"id": "article-142041_11", "title": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products", "content": "The ABO antigen is fully developed at birth; however, newborns do not start making antibodies until 3\u00a0to 6 months of age. The antibodies present in the serum of newborns under four months of age are passively transferred from the mother.\u00a0Therefore when a red cell transfusion is ordered for an infant under four months of age, the mother\u2019s blood type must be considered. [9] Forward typing is performed to determine a newborn\u2019s blood type, but reverse typing is not performed in infants in the first few months of life.", "contents": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products. The ABO antigen is fully developed at birth; however, newborns do not start making antibodies until 3\u00a0to 6 months of age. The antibodies present in the serum of newborns under four months of age are passively transferred from the mother.\u00a0Therefore when a red cell transfusion is ordered for an infant under four months of age, the mother\u2019s blood type must be considered. [9] Forward typing is performed to determine a newborn\u2019s blood type, but reverse typing is not performed in infants in the first few months of life."}
{"id": "article-142041_12", "title": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products", "content": "Platelets have ABO antigens, but the expression is variable; these antigens are only strongly expressed in a minority of patients. Platelets are, however, suspended in plasma containing ABO antibodies.\u00a0 The plasma accompanying the platelets may cause hemolysis if the plasma is not compatible with the recipient\u2019s red blood cells. [10] In the emergency setting for the bleeding patient requiring blood products, group AB plasma, and group O-negative red blood cells have been traditionally transfused to avoid ABO incompatibility and avoid delays while blood typing is being performed.\u00a0 Group AB plasma does not contain Anti-A or Anti-B antibodies and is therefore compatible with all ABO blood groups.\u00a0 The supply of AB plasma is, however, limited. Newer approaches in the emergency treatment of patients without a known ABO blood type include transfusion of type A plasma and low-titer group O whole blood.\u00a0While transfusion of even a small amount of ABO-incompatible red blood cells can lead to severe hemolysis and morbidity, clinically significant hemolysis has not been described in cases of type A plasma or low-titer group O whole blood transfusions into patients for whom these products are ABO-incompatible. [11]", "contents": "ABO Blood Group System -- Issues of Concern -- Choosing the Safest Blood Products. Platelets have ABO antigens, but the expression is variable; these antigens are only strongly expressed in a minority of patients. Platelets are, however, suspended in plasma containing ABO antibodies.\u00a0 The plasma accompanying the platelets may cause hemolysis if the plasma is not compatible with the recipient\u2019s red blood cells. [10] In the emergency setting for the bleeding patient requiring blood products, group AB plasma, and group O-negative red blood cells have been traditionally transfused to avoid ABO incompatibility and avoid delays while blood typing is being performed.\u00a0 Group AB plasma does not contain Anti-A or Anti-B antibodies and is therefore compatible with all ABO blood groups.\u00a0 The supply of AB plasma is, however, limited. Newer approaches in the emergency treatment of patients without a known ABO blood type include transfusion of type A plasma and low-titer group O whole blood.\u00a0While transfusion of even a small amount of ABO-incompatible red blood cells can lead to severe hemolysis and morbidity, clinically significant hemolysis has not been described in cases of type A plasma or low-titer group O whole blood transfusions into patients for whom these products are ABO-incompatible. [11]"}
{"id": "article-142041_13", "title": "ABO Blood Group System -- Clinical Significance", "content": "While there is variability in the ABO phenotype frequencies among different ethnic and racial groups, blood type O is generally the most prevalent worldwide, followed by types A and B, respectively. Type B is more common in the Asian population. Blood type AB is the rarest of the ABO phenotypes. [12] ABO antigens are not only found on red blood cells but are also expressed on the surface of many different types of human cells. The importance of ABO blood type antigens stretches beyond transfusion medicine, as many reports suggest the involvement of the ABO system in several disease processes. ABO blood groups have been linked with the susceptibility to various diseases, including hematologic disorders, cancer, infections, and cardiovascular diseases. [13]", "contents": "ABO Blood Group System -- Clinical Significance. While there is variability in the ABO phenotype frequencies among different ethnic and racial groups, blood type O is generally the most prevalent worldwide, followed by types A and B, respectively. Type B is more common in the Asian population. Blood type AB is the rarest of the ABO phenotypes. [12] ABO antigens are not only found on red blood cells but are also expressed on the surface of many different types of human cells. The importance of ABO blood type antigens stretches beyond transfusion medicine, as many reports suggest the involvement of the ABO system in several disease processes. ABO blood groups have been linked with the susceptibility to various diseases, including hematologic disorders, cancer, infections, and cardiovascular diseases. [13]"}
{"id": "article-142041_14", "title": "ABO Blood Group System -- Clinical Significance", "content": "Clinically significant antibodies can lead to adverse events during transfusion and can also lead to hemolytic disease of the fetus and newborn after placental transmission from mother to fetus.\u00a0 Hemolytic disease of the newborn (HDN) occurs due to incompatibility between the blood of the mother and the baby. Antibodies from the mother cross the placenta during pregnancy and attack the baby\u2019s red blood cells. ABO incompatibility between mother and infant can cause hemolysis and hyperbilirubinemia in the infant.\u00a0 HDN due to ABO incompatibility tends to be less severe than that caused by Rh compatibility because fetal red cells tend to express less of the ABO blood group antigens than adults. Also, the ABO blood group antigens are present on various tissues, which decreases the likelihood that ABO antibodies will bind to their targets on fetal red cells. The degree of severity of hemolysis varies greatly.\u00a0 HDN can occur with the first pregnancy and has a high recurrence rate. [14] [15] [16]", "contents": "ABO Blood Group System -- Clinical Significance. Clinically significant antibodies can lead to adverse events during transfusion and can also lead to hemolytic disease of the fetus and newborn after placental transmission from mother to fetus.\u00a0 Hemolytic disease of the newborn (HDN) occurs due to incompatibility between the blood of the mother and the baby. Antibodies from the mother cross the placenta during pregnancy and attack the baby\u2019s red blood cells. ABO incompatibility between mother and infant can cause hemolysis and hyperbilirubinemia in the infant.\u00a0 HDN due to ABO incompatibility tends to be less severe than that caused by Rh compatibility because fetal red cells tend to express less of the ABO blood group antigens than adults. Also, the ABO blood group antigens are present on various tissues, which decreases the likelihood that ABO antibodies will bind to their targets on fetal red cells. The degree of severity of hemolysis varies greatly.\u00a0 HDN can occur with the first pregnancy and has a high recurrence rate. [14] [15] [16]"}
{"id": "article-142041_15", "title": "ABO Blood Group System -- Clinical Significance", "content": "A hemolytic transfusion reaction is one type of reaction that can occur with the transfusion of blood products. Acute hemolytic transfusion reactions most commonly occur with transfusion of red blood cells, although they can develop with transfusions of other blood products. An acute hemolytic transfusion reaction occurs within 24 hours of the transfusion. Acute hemolytic reactions are most often caused by incompatibility between the donor product and recipient blood group system, most commonly the ABO blood group system. The classic presentation of acute hemolytic transfusion reaction includes fever, red/brown urine, and back/flank pain. However, not all patients will present in this way; other symptoms that may be noted include hypotension, chills, renal failure, and disseminated intravascular coagulation. [17]", "contents": "ABO Blood Group System -- Clinical Significance. A hemolytic transfusion reaction is one type of reaction that can occur with the transfusion of blood products. Acute hemolytic transfusion reactions most commonly occur with transfusion of red blood cells, although they can develop with transfusions of other blood products. An acute hemolytic transfusion reaction occurs within 24 hours of the transfusion. Acute hemolytic reactions are most often caused by incompatibility between the donor product and recipient blood group system, most commonly the ABO blood group system. The classic presentation of acute hemolytic transfusion reaction includes fever, red/brown urine, and back/flank pain. However, not all patients will present in this way; other symptoms that may be noted include hypotension, chills, renal failure, and disseminated intravascular coagulation. [17]"}
{"id": "article-142041_16", "title": "ABO Blood Group System -- Clinical Significance", "content": "Once an acute hemolytic transfusion is suspected, the transfusion should be immediately stopped. The most common cause of death during a transfusion is a clerical error, where an incompatible unit of blood was transfused, and so clerical error should be ruled-out and ensure the correct blood product was given to the intended patient. The remaining blood product, along with a sample of blood from the patient, should be sent to the blood bank for repeat ABO testing on the patient after the reaction. Repeat cross-matching is then performed, and patient samples should be sent to evaluate for renal failure, hemoglobinemia, hemoglobinuria, disseminated intravascular coagulation, and hemolysis. Treatment for an acute hemolytic transfusion reaction is mainly supportive care, and specific treatments are determined by the specific complications noted.", "contents": "ABO Blood Group System -- Clinical Significance. Once an acute hemolytic transfusion is suspected, the transfusion should be immediately stopped. The most common cause of death during a transfusion is a clerical error, where an incompatible unit of blood was transfused, and so clerical error should be ruled-out and ensure the correct blood product was given to the intended patient. The remaining blood product, along with a sample of blood from the patient, should be sent to the blood bank for repeat ABO testing on the patient after the reaction. Repeat cross-matching is then performed, and patient samples should be sent to evaluate for renal failure, hemoglobinemia, hemoglobinuria, disseminated intravascular coagulation, and hemolysis. Treatment for an acute hemolytic transfusion reaction is mainly supportive care, and specific treatments are determined by the specific complications noted."}
{"id": "article-142041_17", "title": "ABO Blood Group System -- Enhancing Healthcare Team Outcomes", "content": "The discovery of the ABO system has led to increased safety in the transfusion of blood products. Understanding the ABO blood group system is essential to ensure appropriate blood products are administered to patients. Practitioners should know the appropriate blood products to transfuse based on ABO typing and recognize typical presentations of ABO incompatibility. Knowledge of the ABO blood system, prevention of complications with appropriate blood product administration, and prompt identification of signs/symptoms of ABO incompatibility will improve patient care and decrease morbidity.", "contents": "ABO Blood Group System -- Enhancing Healthcare Team Outcomes. The discovery of the ABO system has led to increased safety in the transfusion of blood products. Understanding the ABO blood group system is essential to ensure appropriate blood products are administered to patients. Practitioners should know the appropriate blood products to transfuse based on ABO typing and recognize typical presentations of ABO incompatibility. Knowledge of the ABO blood system, prevention of complications with appropriate blood product administration, and prompt identification of signs/symptoms of ABO incompatibility will improve patient care and decrease morbidity."}
{"id": "article-142041_18", "title": "ABO Blood Group System -- Enhancing Healthcare Team Outcomes", "content": "From the bedside to the blood bank, the medical team must collaborate to ensure that transfusions are administered safely to minimize complications. The blood bank team must determine the most appropriate blood product to release. Communication from the clinical team is necessary to provide clinical background and information regarding adverse transfusion-related events to the blood bank team. Administering a transfusion safely can only occur with the teamwork of physicians, advanced care practitioners, nurses, and technologists in the blood bank.", "contents": "ABO Blood Group System -- Enhancing Healthcare Team Outcomes. From the bedside to the blood bank, the medical team must collaborate to ensure that transfusions are administered safely to minimize complications. The blood bank team must determine the most appropriate blood product to release. Communication from the clinical team is necessary to provide clinical background and information regarding adverse transfusion-related events to the blood bank team. Administering a transfusion safely can only occur with the teamwork of physicians, advanced care practitioners, nurses, and technologists in the blood bank."}
{"id": "article-142041_19", "title": "ABO Blood Group System -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "ABO Blood Group System -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}